Long-term hypothyroidism in patients started on levothyroxine during pregnancy

Sophie Demartin,Stefan Matei Constantinescu,Kris G Poppe,Dominique Maiter,Raluca Maria Furnica,Orsalia Alexopoulou,Chantal Daumerie,Frederic Debiève,Maria-Cristina Burlacu

DOI: https://doi.org/10.1530/etj-24-0051

2024-05-30

European Thyroid Journal

Abstract:Background: Current guidelines recommend different post-partum approaches of patients started on levothyroxine (LT4) during pregnancy. Objective We studied post-partum management of these patients and determined factors associated with long-term hypothyroidism. Methods Retrospective study performed in a tertiary center between 2014 and 2020, with LT4 initiation according to 2014 ETA recommendations. We performed multivariate logistic regression (MVR) and a Receiver Operating Characteristic (ROC) curve analysis to determine variables associated with long-term hypothyroidism and their optimal cut-offs. Results LT4 was initiated in 177 pregnant women and 106/177 (60%) were followed at long-term (at least 6 months post-partum) (28.5 [9.0-81.9] months). LT4 could have been stopped in 45% patients who continued it immediately after delivery. Thirty-six/106 (34%) patients were long-term hypothyroid. In them, LT4 was initiated earlier during pregnancy than in euthyroid women (11.7 ± 4.7 vs. 13.7 ± 6.5 weeks, p=0.077), at a higher TSH level (4.1 [2.2-10.1] vs. 3.5 [0.9-6.9] mU/l, p=0.005) and reached a higher dose during pregnancy (62.8 ± 22.2 vs. 50.7 ± 13.9 μg/day, p=0.005). In the MVR only the maximal LT4 dose during pregnancy was associated with long-term hypothyroidism (OR=1.03, 95% CI 1.00-1.05, p=0.003). The optimal cut-offs for predicting long-term hypothyroidism were a LT4 dose of 68.75 μg/day (87% specificity, 42% sensitivity; p=0.013) and a TSH level ≥ 3.8 mU/l (68.5% specificity, 77% sensitivity; p=0.019). Conclusion One-third of patients started on LT4 during pregnancy had long-term hypothyroidism. The TSH level at treatment initiation and the LT4 dose during pregnancy could guide the decision for continuing long-term LT4.

endocrinology & metabolism